Prenetics Global Ltd. (PRENW) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Prenetics Global Ltd. (PRENW:NASDAQ), powered by AI.

Current Price
$0.02
Sector
Healthcare
What is the Prenetics Global Ltd. stock price forecast?

Prenetics Global Ltd. is currently trading at $0.02. View real-time AI analysis on Alpha Lenz.

What is Prenetics Global Ltd. insider trading activity?

View the latest insider trading data for Prenetics Global Ltd. on Alpha Lenz.

What is Prenetics Global Ltd.'s P/E ratio?

View Prenetics Global Ltd.'s valuation metrics on Alpha Lenz.

Prenetics Global Ltd.

NASDAQ · PRENW
$0.02
Ask about Prenetics Global Ltd.'s future dividend policy...
Alpha Chat Insight

Prenetics Global Ltd.'s ROE is -24.6%. Explore profitability and growth together.

Ask for details

Company Overview

Prenetics Global Ltd. is a biotechnology company known for its dynamic role in the field of genetic testing and health diagnostics. Its primary function is to provide advanced solutions for personalized healthcare, specializing in genomics testing, which includes genetic predisposition tests and diagnostic services for various health conditions. The company’s cutting-edge technology supports sectors such as healthcare, pharmaceuticals, and consumer wellness, offering individuals and healthcare professionals the information needed to make informed health decisions. Prenetics is significantly recognized for its contributions to preventive healthcare and its role in empowering consumers with access to their genetic information. By doing so, it plays a pivotal part in the broader movement towards personalized medicine, helping to tailor healthcare experiences to individual genetic profiles. Based in Hong Kong, Prenetics is strategically positioned to serve the expanding Asian market and beyond, aligning with global trends emphasizing the integration of technology in healthcare. The company’s operations underscore an important shift in the healthcare paradigm, focusing on proactive approaches rather than reactive treatment, making it a key player in the future of biotech innovation.

CEOMr. Sheng Wu Yeung
SectorHealthcare
IndustryDiagnostics & Research
Employees285

Company Statistics

FY 2024

Profile

N/AMarket Cap
$30.62MRevenue
0.00Shares Out
285Employees

Margins

50.29%Gross
-144.72%EBITDA
-166.19%Operating
-188.44%Pre-Tax
-162.65%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

34.69%Rev 3Yr
27.10%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-21.30%ROA
-24.58%ROE
-24.59%ROIC

Financial Health

$52.25MCash & Cash Equivalents
$-10.02MNet Debt
24.65%Debt/Equity
N/AInterest Cov
Alpha Chat Insight

Prenetics Global Ltd.'s ROE is -24.6%. Explore profitability and growth together.

Ask for details

Frequently Asked Questions

Prenetics Global Ltd. (ticker: PRENW) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 285 employees.

The current price is $0.018 with a P/E ratio of -x and P/B of -x.

ROE is -24.58% and operating margin is -166.19%. Annual revenue is $31M.

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Prenetics Global Ltd. (Healthcare) Stock Forecast & Analysis $0.02 | Alpha Lenz